The SciLifeLab The Svedberg seminar series has been ongoing since the mid-70’s, inviting leading bioscientists from all over the world to give insights into their research. Olof Eriksson, PET Imaging Director at Antaros Medical and Associate Senior Lecturer at Uppsala University, will hold a seminar in this series on Monday, November 30, talking about the value of using positron emission tomography (PET) to understand the complex biology of diabetes.
A major research area within clinical drug development for diabetes, obesity and metabolism are the unimolecular dual or trimodal agonists which simultaneously act on several different gut hormone receptors to help control of glucose metabolism. These include the glucagon receptor, as well as the incretin glucagon like peptide-1 (GLP-1) and gastric inhibitory polypeptide (GIP) receptors. PET tracers binding to these receptors can help to understand the optimal efficacy of incretin agonists through understanding their pharmacodynamic (PD) and pharmacokinetic (PK) effects.
In his seminar on the 30th of November at 15.15-16.15 (CET), Olof will talk about these PET tracers and how PET can be used to increase our understanding of the development of metabolic disease.
Read more about the talk and join in here: https://www.scilifelab.se/event/scilifelab-the-svedberg-seminar-series-olof-eriksson/